CPT 2015: New drug screen codes — Overhaul may make cheat sheets mandatory

Why This Topic Matters

Drug screening code revisions can affect claim reporting, payer policy alignment, and day-to-day coding workflow. Understanding the scope of the changes helps organizations prepare reference materials and monitor whether Medicare and commercial payers adopt the updated code structure.

Article Sections

1. Overview of the 2015 drug screen code revision

   Introduces the scope and timing of the coding overhaul and why reference tools may be helpful. Summarizes the broader impact on drug screening workflow and code organization.

2. Examples of code crosswalk challenges

   Discusses how new drug screen reporting categories relate to previously used drug test codes and why mapping between old and new reporting structures may be important. Focuses on the general transition issues rather than detailed selection guidance.

3. Benzodiazepine testing split

   Notes a specific example of a drug class code being divided into separate reporting options. Places this change in the context of the wider CPT update.

4. Payer adoption and reimbursement watch points

   Covers the possibility of Medicare and commercial payer responses to the updated coding structure. Highlights the need to monitor fee schedule and payer policy decisions.